scholarly article | Q13442814 |
P356 | DOI | 10.1111/ANDR.12313 |
P8608 | Fatcat ID | release_423z6bnubnfflpfxnqmndg6h7e |
P932 | PMC publication ID | 5352463 |
P698 | PubMed publication ID | 28076881 |
P2093 | author name string | A L Burnett | |
B Musicki | |||
P2860 | cites work | Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 | Q27860575 |
Nitric oxide synthases: regulation and function | Q28247092 | ||
Angiotensin II-mediated posttranslational modification of nNOS in the PVN of rats with CHF: role for PIN. | Q29346995 | ||
Increased phosphodiesterase type 5 levels in a mouse model of type 2 diabetes mellitus | Q30455848 | ||
Treatment of erectile dysfunction in the obese type 2 diabetic ZDF rat with adipose tissue-derived stem cells | Q33994488 | ||
Akt-dependent phosphorylation of endothelial nitric-oxide synthase mediates penile erection | Q34021698 | ||
Role of neural NO synthase (nNOS) uncoupling in the dysfunctional nitrergic vasorelaxation of penile arteries from insulin-resistant obese Zucker rats. | Q34249452 | ||
Signaling properties of 4-hydroxyalkenals formed by lipid peroxidation in diabetes | Q34366394 | ||
Erectile dysfunction in young non-obese type II diabetic Goto-Kakizaki rats is associated with decreased eNOS phosphorylation at Ser1177 | Q34498189 | ||
Regulation of endothelial-type NO synthase expression in pathophysiology and in response to drugs. | Q34967386 | ||
Functional, metabolic, and morphologic characteristics of a novel rat model of type 2 diabetes-associated erectile dysfunction | Q35154128 | ||
Mouse model of erectile dysfunction due to diet-induced diabetes mellitus | Q36464498 | ||
Endothelial dysfunction in diabetic erectile dysfunction | Q36507302 | ||
Low-fat diet and exercise preserve eNOS regulation and endothelial function in the penis of early atherosclerotic pigs: a molecular analysis | Q37087758 | ||
Protein tyrosine nitration--functional alteration or just a biomarker? | Q37156028 | ||
Type 1 and Type 2 diabetic-erectile dysfunction: same diagnosis (ICD-9), different disease? | Q37408349 | ||
Nox family NADPH oxidases: Molecular mechanisms of activation | Q38243365 | ||
Thirty Years of Saying NO: Sources, Fate, Actions, and Misfortunes of the Endothelium-Derived Vasodilator Mediator | Q38889867 | ||
Sildenafil promotes eNOS activation and inhibits NADPH oxidase in the transgenic sickle cell mouse penis | Q39290264 | ||
Mechanistic link between erectile dysfunction and systemic endothelial dysfunction in type 2 diabetic rats | Q41698843 | ||
Diabetes exacerbates the functional deficiency of NO/cGMP pathway associated with erectile dysfunction in human corpus cavernosum and penile arteries | Q43242619 | ||
Bladder and erectile dysfunctions in the Type 2 diabetic Goto-Kakizaki rat. | Q43472299 | ||
Increased expression of arginase II in human diabetic corpus cavernosum: in diabetic-associated erectile dysfunction | Q43605519 | ||
Cavernosal tissue nitrite, nitrate, malondialdehyde and glutathione levels in diabetic and non-diabetic erectile dysfunction | Q44503882 | ||
Serum biomarker measurements of endothelial function and oxidative stress after daily dosing of sildenafil in type 2 diabetic men with erectile dysfunction | Q45310756 | ||
Early onset of fibrosis within the arterial media in a rat model of type 2 diabetes mellitus with erectile dysfunction. | Q46025702 | ||
Reduction of penile nitric oxide synthase in diabetic BB/WORdp (type I) and BBZ/WORdp (type II) rats with erectile dysfunction | Q46369985 | ||
Clinical, socioeconomic, and lifestyle parameters associated with erectile dysfunction among diabetic men. | Q46570745 | ||
Diagnostic value of nitric oxide, lipoprotein(a), and malondialdehyde levels in the peripheral venous and cavernous blood of diabetics with erectile dysfunction | Q46571184 | ||
Erectile dysfunction in the type II diabetic db/db mouse: impaired venoocclusion with altered cavernosal vasoreactivity and matrix | Q46713746 | ||
Assessment of erectile dysfunction in diabetic patients | Q46734901 | ||
Beneficial effect of the soluble guanylyl cyclase stimulator BAY 41-2272 on impaired penile erection in db/db-/- type II diabetic and obese mice. | Q53594364 | ||
Altered Penile Vascular Reactivity and Erection in the Zucker Obese-Diabetic Rat | Q57465093 | ||
Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction | Q73359029 | ||
Identification of neuronal nitric oxide synthase (nNOS) in human penis: a potential role of reduced neuronally-derived nitric oxide in erectile dysfunction | Q83910925 | ||
TNF-α, erectile dysfunction, and NADPH oxidase-mediated ROS generation in corpus cavernosum in high-fat diet/streptozotocin-induced diabetic rats | Q83958302 | ||
Abnormal protein expression in the corpus cavernosum impairs erectile function in type 2 diabetes | Q84554742 | ||
Assessment of androgen replacement therapy for erectile function in rats with type 2 diabetes mellitus by examining nitric oxide-related and inflammatory factors | Q87171728 | ||
P433 | issue | 2 | |
P304 | page(s) | 294-298 | |
P577 | publication date | 2017-01-11 | |
P1433 | published in | Andrology | Q26839702 |
P1476 | title | Constitutive NOS uncoupling and NADPH oxidase upregulation in the penis of type 2 diabetic men with erectile dysfunction | |
P478 | volume | 5 |